Literature DB >> 22811879

Management of gastrointestinal carcinoid tumours - 10 years experience at a district general hospital.

Shridhar S Dronamraju1, Vickram B Joypaul.   

Abstract

BACKGROUND: There is paucity of guidelines regarding management of gastrointestinal carcinoid tumours in district hospitals.
METHODS: This study was undertaken at a district hospital to analyse the management pathway of gastrointestinal carcinoid tumours.
RESULTS: Over a period of 10 years there were 35 patients, with an estimated annual incidence of 2.5 per 100,000 population. After a median follow up of 24 months, 22 (63%) patients were alive and disease free. Only 56% patients were referred to the regional neuro-endocrine multidisciplinary team.
CONCLUSIONS: Management of patients with carcinoid tumours in district hospitals needs streamling with increased utilisation of regional neuroendocrine multidisciplinary teams.

Entities:  

Keywords:  Gastrointestinal carcinoid tumours; district hospital; neuro-endocrine tumours

Year:  2012        PMID: 22811879      PMCID: PMC3397653          DOI: 10.3978/j.issn.2078-6891.2011.039

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  57 in total

1.  Carcinoembryonic antigen and carcinoids of the gastrointestinal tract.

Authors:  B H Federspiel; A P Burke; K M Shekitka; L H Sobin
Journal:  Mod Pathol       Date:  1990-09       Impact factor: 7.842

Review 2.  Revised classification of neuroendocrine tumours of the lung, pancreas and gut.

Authors:  C Capella; P U Heitz; H Höfler; E Solcia; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

3.  Colonic carcinoid tumors: a clinicopathologic study of 23 patients from a single institution.

Authors:  Daniel Reis Waisberg; Antonio Sergio Fava; Lourdes Conceição Martins; Leandro Luongo Matos; Maria Isete Fares Franco; Jaques Waisberg
Journal:  Arq Gastroenterol       Date:  2009 Oct-Dec

4.  Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry.

Authors:  G H Ballantyne; P E Savoca; J T Flannery; M H Ahlman; I M Modlin
Journal:  Cancer       Date:  1992-05-15       Impact factor: 6.860

5.  Classification of low-grade neuroendocrine tumors of midgut and unknown origin.

Authors:  Susanne Van Eeden; Pascal F H J Quaedvlieg; Babs G Taal; G Johan A Offerhaus; Cornelis B H W Lamers; Marie-Louise F Van Velthuysen
Journal:  Hum Pathol       Date:  2002-11       Impact factor: 3.466

6.  An analysis of 8305 cases of carcinoid tumors.

Authors:  I M Modlin; A Sandor
Journal:  Cancer       Date:  1997-02-15       Impact factor: 6.860

7.  Carcinoid tumors of the rectum: effect of size, histopathology, and surgical treatment on metastasis free survival.

Authors:  A N Koura; G G Giacco; S A Curley; J M Skibber; B W Feig; L M Ellis
Journal:  Cancer       Date:  1997-04-01       Impact factor: 6.860

8.  Radiofrequency ablation treatment of refractory carcinoid hepatic metastases.

Authors:  F J Wessels; S R Schell
Journal:  J Surg Res       Date:  2001-01       Impact factor: 2.192

Review 9.  Carcinoid tumour of the appendix.

Authors:  A C Goede; M E Caplin; M C Winslet
Journal:  Br J Surg       Date:  2003-11       Impact factor: 6.939

Review 10.  One hundred years after "carcinoid": epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States.

Authors:  James C Yao; Manal Hassan; Alexandria Phan; Cecile Dagohoy; Colleen Leary; Jeannette E Mares; Eddie K Abdalla; Jason B Fleming; Jean-Nicolas Vauthey; Asif Rashid; Douglas B Evans
Journal:  J Clin Oncol       Date:  2008-06-20       Impact factor: 44.544

View more
  3 in total

1.  EndoVascular Occlusion and Tumor Excision (EVOTE): a Hybrid Approach to Small-Bowel Neuroendocrine Tumors with Mesenteric Metastases.

Authors:  Julian K Horwitz; Michael L Marin; Richard R P Warner; Robert A Lookstein; Celia M Divino
Journal:  J Gastrointest Surg       Date:  2019-05-14       Impact factor: 3.452

2.  Vitamin D and vitamin B12 deficiencies in patients with small intestinal carcinoid tumour: is opioid use disorder a confounding factor in the diagnosis?

Authors:  Richard Fagan; Syed Sabeeh Najam Bokhari; Faisal Inayat
Journal:  BMJ Case Rep       Date:  2019-03-16

3.  Performance of Multidetector Computed Tomography and Negative Versus Positive Enteric Contrast for Evaluation of Gastrointestinal Neuroendocrine Neoplasms.

Authors:  Ajaykumar C Morani; Shiva Gupta; Khaled M Elsayes; Ahmad I Mubarak; Ahmed M Khalaf; Priya R Bhosale; Jia Sun; Corey T Jensen; Vikas Kundra
Journal:  J Comput Assist Tomogr       Date:  2022-03-04       Impact factor: 2.081

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.